Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease: A Systematic Literature Review
- PMID: 39938492
- PMCID: PMC12324975
- DOI: 10.1159/000543160
Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease: A Systematic Literature Review
Abstract
Introduction: Neuropsychiatric symptoms (NPS) such as increased apathy, affective symptoms, psychosis and hyperactivity are common in Alzheimer's disease (AD) and are associated with increased disease severity and caregiver burden. In contrast to well-characterized associations between AD-related cognitive deficits and focal neuropathology (e.g., memory and hippocampal atrophy), fewer studies have focused on associations between NPS-brain associations in AD. Furthermore, studies focusing on magnetic resonance imaging measures of gray matter (GM) abnormalities associated with NPS in AD have not been systematically reviewed.
Methods: To address this gap, a systematic literature review was undertaken to identify articles that assessed structural brain differences associated with NPS in AD. This review identified 29 such articles that tested associations between NPS and gray matter loss (GML: reduced GM density, reduced GM volume, decreased cortical thickness, etc.).
Results: Across all NPS, most symptoms were associated with GML in the prefrontal cortex and medial temporal lobe, highlighting key limbic/limbic adjacent structures including orbitofrontal cortex and parahippocampal regions. Other regions exhibiting associations included the superior and middle temporal gyri as well as anterior and posterior cingulate cortex.
Conclusion: Understanding how GM changes in the brain relate to NPS in AD may not only improve our understanding of NPS and AD but may also provide help identify homologies/correspondence with brain changes in psychiatric diseases.
Keywords: Alzheimer’s disease; Magnetic resonance imaging; Neuropsychiatric symptoms.
© 2025 S. Karger AG, Basel.
Conflict of interest statement
Conflict of Interest Statement
The authors have no conflicts of interest to declare.
References
-
- Tariot PN et al. , “The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer’s Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer’s Disease,” Am J Psychiatry, vol. 152, no. 9, pp. 1349–1357, Sep. 1995, doi: 10.1176/ajp.152.9.1349. - DOI - PubMed
-
- Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, and DeKosky S, “Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study,” JAMA, vol. 288, no. 12, pp. 1475–1483, Sep. 2002, doi: 10.1001/jama.288.12.1475. - DOI - PubMed
-
- Vik-Mo AO, Giil LM, Borda MG, Ballard C, and Aarsland D, “The individual course of neuropsychiatric symptoms in people with Alzheimer’s and Lewy body dementia: 12-year longitudinal cohort study,” The British Journal of Psychiatry, vol. 216, no. 1, pp. 43–48, Jan. 2020, doi: 10.1192/bjp.2019.195. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous